Furthermore, we have demonstrated that this results in elevated levels of expression of Ubc9 both at the RNA as well as protein levels in these BRCA1 Ubc9 mutant UWB1.289 ovarian cancer and HCC1937 TNBC cells. This evidence concerns the gene UBE2I and ovarian cancer.